Staffan joined Investor Growth Capital Europe (Stockholm) in 1999. His 18 years of industry experience includes acting as Head of the Pharmacia BioScience Center and Vice President of Corporate R&D, Head of Preclinical R&D and Vice President (Biopharmaceuticals), Pharmacia AB, and Head of Operations, Planning and Development, Pharmacia & Upjohn. Staffan is currently Secretary General of the Heart-Lung Foundation in Sweden, a fund donating money for preclinical and clinical research on heart and lung diseases.Staffan holds a Ph.D. in Organic Chemistry from the University of Stockholm, where he is also a Professor.
© Investor AB, Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden. Telephone: +46 8 614 20 00 | Cookies
This website is not intended to offer or to promote the offer or sale of Investor AB securities in the United States or to U. S. persons